Literature DB >> 26506440

Penetrance of pathogenic mutations in haploinsufficient genes for intellectual disability and related disorders.

H Hilger Ropers1, Thomas Wienker2.   

Abstract

De novo loss of function (LOF) mutations in the ASXL3 gene cause Bainbridge-Ropers syndrome, a severe form of intellectual disability (ID) and developmental delay, but there is evidence that they also occur in healthy individuals. This has prompted us to look for non-pathogenic LOF variants in other ID genes. Heterozygous LOF mutations in ASXL1, a paralog of ASXL3, are known to cause Bohring-Opitz syndrome (BOS), and benign LOF mutations in this gene have not been published to date. Therefore, we were surprised to find 56 ASXL1 LOF variants in the ExAC database (http://exac.broadinstitute.org), comprising exomes from 60,706 individuals who had been selected to exclude severe genetic childhood disorders. 4 of these variants have been described as disease-causing in patients with BOS, which rules out the possibility that pathogenic and clinically neutral LOF variants in this gene are functionally distinct. Apparently benign LOF variants were also detected in several other genes for ID and related disorders, including CDH15, KATNAL2, DEPDC5, ARID1B and AUTS2, both in the ExAC database and in the 6,500 exomes of the Exome Variant Server (http://evs.gs.washington.edu/EVS/). These observations argue for low penetrance of LOF mutations in ASXL1 and other genes for ID and related disorders, which could have far-reaching implications for genetic counseling and research.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26506440     DOI: 10.1016/j.ejmg.2015.10.007

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  13 in total

1.  Risks and Recommendations in Prenatally Detected De Novo Balanced Chromosomal Rearrangements from Assessment of Long-Term Outcomes.

Authors:  Christina Halgren; Nete M Nielsen; Lusine Nazaryan-Petersen; Asli Silahtaroglu; Ryan L Collins; Chelsea Lowther; Susanne Kjaergaard; Morten Frisch; Maria Kirchhoff; Karen Brøndum-Nielsen; Allan Lind-Thomsen; Yuan Mang; Zahra El-Schich; Claire A Boring; Mana M Mehrjouy; Peter K A Jensen; Christina Fagerberg; Lotte N Krogh; Jan Hansen; Thue Bryndorf; Claus Hansen; Michael E Talkowski; Mads Bak; Niels Tommerup; Iben Bache
Journal:  Am J Hum Genet       Date:  2018-05-24       Impact factor: 11.025

2.  Bainbridge-Ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition.

Authors:  Alma Kuechler; Johanna Christina Czeschik; Elisabeth Graf; Ute Grasshoff; Ulrike Hüffmeier; Tiffany Busa; Stefanie Beck-Woedl; Laurence Faivre; Jean-Baptiste Rivière; Ingrid Bader; Johannes Koch; André Reis; Ute Hehr; Olaf Rittinger; Wolfgang Sperl; Tobias B Haack; Thomas Wieland; Hartmut Engels; Holger Prokisch; Tim M Strom; Hermann-Josef Lüdecke; Dagmar Wieczorek
Journal:  Eur J Hum Genet       Date:  2016-11-30       Impact factor: 4.246

3.  Analysis of large-scale whole exome sequencing data to determine the prevalence of genetically-distinct forms of neuronal ceroid lipofuscinosis.

Authors:  David E Sleat; Erika Gedvilaite; Yeting Zhang; Peter Lobel; Jinchuan Xing
Journal:  Gene       Date:  2016-08-20       Impact factor: 3.688

Review 4.  Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz Syndrome.

Authors:  Colleen M Carlston; Anne H O'Donnell-Luria; Hunter R Underhill; Beryl B Cummings; Ben Weisburd; Eric V Minikel; Daniel P Birnbaum; Tatiana Tvrdik; Daniel G MacArthur; Rong Mao
Journal:  Hum Mutat       Date:  2017-03-21       Impact factor: 4.878

5.  Functional variants in TBX2 are associated with a syndromic cardiovascular and skeletal developmental disorder.

Authors:  Ning Liu; Kelly Schoch; Xi Luo; Loren D M Pena; Venkata Hemanjani Bhavana; Mary K Kukolich; Sarah Stringer; Zöe Powis; Kelly Radtke; Cameron Mroske; Kristen L Deak; Marie T McDonald; Allyn McConkie-Rosell; M Louise Markert; Peter G Kranz; Nicholas Stong; Anna C Need; David Bick; Michelle D Amaral; Elizabeth A Worthey; Shawn Levy; Michael F Wangler; Hugo J Bellen; Vandana Shashi; Shinya Yamamoto
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

6.  De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.

Authors:  Vandana Shashi; Loren D M Pena; Katherine Kim; Barbara Burton; Maja Hempel; Kelly Schoch; Magdalena Walkiewicz; Heather M McLaughlin; Megan Cho; Nicholas Stong; Scott E Hickey; Christine M Shuss; Michael S Freemark; Jane S Bellet; Martha Ann Keels; Melanie J Bonner; Maysantoine El-Dairi; Megan Butler; Peter G Kranz; Constance T R M Stumpel; Sylvia Klinkenberg; Karin Oberndorff; Malik Alawi; Rene Santer; Slavé Petrovski; Outi Kuismin; Satu Korpi-Heikkilä; Olli Pietilainen; Palotie Aarno; Mitja I Kurki; Alexander Hoischen; Anna C Need; David B Goldstein; Fanny Kortüm
Journal:  Am J Hum Genet       Date:  2016-09-29       Impact factor: 11.025

7.  Quantifying the contribution of recessive coding variation to developmental disorders.

Authors:  Hilary C Martin; Wendy D Jones; Rebecca McIntyre; Gabriela Sanchez-Andrade; Mark Sanderson; James D Stephenson; Carla P Jones; Juliet Handsaker; Giuseppe Gallone; Michaela Bruntraeger; Jeremy F McRae; Elena Prigmore; Patrick Short; Mari Niemi; Joanna Kaplanis; Elizabeth J Radford; Nadia Akawi; Meena Balasubramanian; John Dean; Rachel Horton; Alice Hulbert; Diana S Johnson; Katie Johnson; Dhavendra Kumar; Sally Ann Lynch; Sarju G Mehta; Jenny Morton; Michael J Parker; Miranda Splitt; Peter D Turnpenny; Pradeep C Vasudevan; Michael Wright; Andrew Bassett; Sebastian S Gerety; Caroline F Wright; David R FitzPatrick; Helen V Firth; Matthew E Hurles; Jeffrey C Barrett
Journal:  Science       Date:  2018-11-08       Impact factor: 47.728

8.  Two loss-of-function ANKRD11 variants in Chinese patients with short stature and a possible molecular pathway.

Authors:  Tingting Zhang; Yun Yang; Xueling Yin; Xueqing Wang; Jihong Ni; Zhiya Dong; Chuanyin Li; Wenli Lu
Journal:  Am J Med Genet A       Date:  2020-12-22       Impact factor: 2.802

9.  ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen.

Authors:  Liang Wang; Yinfeng Lyu; Yuqing Li; Kunping Li; Hui Wen; Chenchen Feng; Ning Li
Journal:  Aging (Albany NY)       Date:  2021-09-18       Impact factor: 5.682

10.  Population data improves variant interpretation in autosomal dominant polycystic kidney disease.

Authors:  Amali C Mallawaarachchi; Timothy J Furlong; John Shine; Peter C Harris; Mark J Cowley
Journal:  Genet Med       Date:  2018-10-29       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.